Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 3;17(7):2197-2204.
doi: 10.1080/21645515.2020.1857201. Epub 2021 Feb 10.

Meningococcal vaccines in China

Yinghua Xu  1 , Yanan Li  1 , Shanshan Wang  1 , Maoguang Li  1 , Miao Xu  1 , Qiang Ye  1
Affiliations

Meningococcal vaccines in China

Yinghua Xu et al. Hum Vaccin Immunother. .

Abstract

Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningococcal vaccination was introduced in the 1980s. Currently, there are polysaccharide, conjugate, and combined vaccine formulations against meningococcal meningitis in the Chinese market, almost all of which are produced by domestic manufacturers. It is necessary to further enhance national meningococcal surveillance to improve the level of prevention and control of meningococcus. However, the immune efficacy and persistence of immunity of vaccines should be monitored. More importantly, additional investments should be made to develop serogroup B meningococcal vaccines.

Keywords: China; Neisseria meningitidis; conjugate vaccines; invasive meningococcal disease; polysaccharides vaccines; quality control.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
Reported meningococcal meningitis and death cases in China, 2002–2019
Figure 2.
Figure 2.
Number of lot release of different types of meningococcal vaccines in China, 2010–2019
See this image and copyright information in PMC

References

    1. Dwilow R, Fanella S.. Invasive meningococcal disease in the 21st century-an update for the clinician. Curr Neurol Neurosci Rep. 2015;15(3):2. doi: 10.1007/s11910-015-0524-6. - DOI - PubMed
    1. Harrison OB, Claus H, Jiang Y, Bennett JS, Bratcher HB, Jolley KA, Corton C, Care R, Poolman JT, Zollinger WD. Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis. 2013;19(4):566–73. doi: 10.3201/eid1904.111799. - DOI - PMC - PubMed
    1. Brooks R, Woods CW, Benjamin DK Jr., Rosenstein NE. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis. 2006;43(1):49–54. doi: 10.1086/504804. - DOI - PubMed
    1. Laver JR, Hughes SE, Read RC. Neisserial molecular adaptations to the nasopharyngeal niche. Adv Microb Physiol. 2015;66:323–55. - PubMed
    1. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–20. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources